Autonomix Medical, Valuation

AMIX Stock   3.97  0.51  11.38%   
At this time, the firm appears to be overvalued. Autonomix Medical, Common shows a prevailing Real Value of USD2.61 per share. The current price of the firm is USD3.97. Our model approximates the value of Autonomix Medical, Common from analyzing the firm fundamentals such as Current Valuation of 3.85 M, shares owned by insiders of 27.20 %, and Return On Equity of -270.17 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Autonomix Medical,'s valuation include:
Price Book
2.6153
Enterprise Value
3.9 M
Overvalued
Today
3.97
Please note that Autonomix Medical,'s price fluctuation is extremely dangerous at this time. Calculation of the real value of Autonomix Medical, Common is based on 3 months time horizon. Increasing Autonomix Medical,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Autonomix Medical, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Autonomix Stock. However, Autonomix Medical,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.97 Real  2.61 Target  1.4 Hype  4.53 Naive  0.13
The intrinsic value of Autonomix Medical,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Autonomix Medical,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.61
Real Value
16.00
Upside
Estimating the potential upside or downside of Autonomix Medical, Common helps investors to forecast how Autonomix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Autonomix Medical, more accurately as focusing exclusively on Autonomix Medical,'s fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.457.1510.84
Details
Hype
Prediction
LowEstimatedHigh
0.234.5317.92
Details
Naive
Forecast
LowNext ValueHigh
00.1313.53
Details
1 Analysts
Consensus
LowTarget PriceHigh
1.271.401.55
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Autonomix Medical,'s intrinsic value based on its ongoing forecasts of Autonomix Medical,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Autonomix Medical,'s closest peers.

Autonomix Medical, Cash

9.04 Million

Autonomix Valuation Trend

Analysing the historical paterns of Autonomix Medical,'s enterprise value and its market capitalization is a good way to estimate and gauge the value of Autonomix Medical, Common over time and is usually enough for investors to make rational market timing decisions.

Autonomix Medical, Total Value Analysis

Autonomix Medical, Common is presently forecasted to have valuation of 3.85 M with market capitalization of 7.92 M, debt of 1 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Autonomix Medical, fundamentals before making equity appraisal based on enterprise value of the company

Autonomix Medical, Asset Utilization

One of the ways to look at asset utilization of Autonomix is to check how much profit was generated for every dollar of assets it reports. Autonomix Medical, Common shows a negative utilization of assets of -1.76 percent, losing USD0.0176 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Autonomix Medical, Common shows how discouraging it operates for each dollar spent on its assets.
 
Covid

Autonomix Medical, Ownership Allocation

Autonomix Medical, Common retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.

Autonomix Medical, Profitability Analysis

Net Loss for the year was (15.43 M) with profit before overhead, payroll, taxes, and interest of 0.

About Autonomix Medical, Valuation

Our relative valuation model uses a comparative analysis of Autonomix Medical,. We calculate exposure to Autonomix Medical,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Autonomix Medical,'s related companies.
Last ReportedProjected for Next Year
Gross Profit-72.9 K-76.5 K

Autonomix Medical, Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding731.3 K

Autonomix Medical, Current Valuation Indicators

Valuation refers to the process of determining the present value of Autonomix Medical, Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Autonomix we look at many different elements of the entity such as Autonomix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Autonomix Medical,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Autonomix Medical,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Autonomix Medical,'s worth.

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.